By Allissa Wickham ( August 13, 2014, 5:09 PM EDT) -- Attorneys for end-payor plaintiffs accusing Mutual Pharmaceutical Co. Inc. of colluding with King Pharmaceuticals Inc. to delay generic versions of the muscle relaxant Skelaxin asked a Tennessee federal court to grant them $3 million in fees on Tuesday, arguing that the litigation's risks and difficulties merited the award....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.